Abstract
The internal control and risk management of drug research and development enterprises directly affects the survival and development of enterprises. With the development of information technology and the integration with the global economy, pharmaceutical companies are able to achieve more achievements in development while facing increasing competitive pressures. Finance is a pivotal spine of a company’s development. If the internal control and risk management of a company are not complete and comprehensive, the enterprise will inevitably turn into a crisis. Therefore, it is necessary to strengthen the analysis of the problems in the internal control and risk management of drug research and development enterprises, and propose corresponding solutions.